Bryan Bennett PhD is the Head of Patient Centered Outcomes at Jazz Pharmaceuticals, bringing over two decades of extensive experience in Clinical Outcome Assessments (COAs) across clinical practice in neuropsychology, academic, and pharmaceutical industry settings. He is a recognized expert in developing and implementing comprehensive outcome strategies that prioritize the patient voice in drug development. Bryan’s work focuses on integrating robust, patient-centric endpoints into clinical trials to ensure treatments deliver clinically meaningful benefits. He has extensive experience in oncology and neuroscience therapy areas. Bryan is a strong advocate for rigorous COA methodologies and regulatory alignment. He is passionate about bridging the gap between clinical research and the real-world needs of patients.